Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity

Zachary Bohart; Khashayar Dashtipour; Heakyung Kim; Marc Schwartz; Aleks Zuzek; Ritu Singh; Mariana Nelson

doi:10.1016/j.toxicon.2024.107678

Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity

Zachary Bohart, Khashayar Dashtipour, Heakyung Kim, Marc Schwartz, Aleks Zuzek, Ritu Singh, Mariana Nelson

Neurology

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	107678
Journal	Toxicon
Volume	241
DOIs	https://doi.org/10.1016/j.toxicon.2024.107678
State	Published - Apr 2024

ASJC Scopus Subject Areas

Toxicology

Keywords

Botulinum toxins type a
Drug utilization
Muscle spasticity
abobotulinumtoxinA
onabotulinumtoxinA

Access to Document

10.1016/j.toxicon.2024.107678

OpenUrl availability

Full text

Cite this

@article{42af1e0ab5f447b98032dacb35a472a8,

title = "Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity",

keywords = "Botulinum toxins type a, Drug utilization, Muscle spasticity, abobotulinumtoxinA, onabotulinumtoxinA",

author = "Zachary Bohart and Khashayar Dashtipour and Heakyung Kim and Marc Schwartz and Aleks Zuzek and Ritu Singh and Mariana Nelson",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2024",

month = apr,

doi = "10.1016/j.toxicon.2024.107678",

language = "English",

volume = "241",

journal = "Toxicon",

issn = "0041-0101",

}

TY - JOUR

T1 - Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity

AU - Bohart, Zachary

AU - Dashtipour, Khashayar

AU - Kim, Heakyung

AU - Schwartz, Marc

AU - Zuzek, Aleks

AU - Singh, Ritu

AU - Nelson, Mariana

PY - 2024/4

Y1 - 2024/4

KW - Botulinum toxins type a

KW - Drug utilization

KW - Muscle spasticity

KW - abobotulinumtoxinA

KW - onabotulinumtoxinA

UR - http://www.scopus.com/inward/record.url?scp=85187549458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85187549458&partnerID=8YFLogxK

U2 - 10.1016/j.toxicon.2024.107678

DO - 10.1016/j.toxicon.2024.107678

M3 - Article

C2 - 38447766

AN - SCOPUS:85187549458

SN - 0041-0101

VL - 241

JO - Toxicon

JF - Toxicon

M1 - 107678

ER -

Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this